Artivion (AORT) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

AORT Stock Forecast


Artivion stock forecast is as follows: an average price target of $30.60 (represents a 14.82% upside from AORT’s last price of $26.65) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

AORT Price Target


The average price target for Artivion (AORT) is $30.60 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $33.00 to $30.00. This represents a potential 14.82% upside from AORT's last price of $26.65.

AORT Analyst Ratings


Buy

According to 4 Wall Street analysts, Artivion's rating consensus is 'Buy'. The analyst rating breakdown for AORT stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Artivion Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2024Daniel StauderJMP Securities$33.00$26.5324.39%23.83%
Aug 09, 2024Suraj KaliaOppenheimer$30.00$25.3318.44%12.57%
Jul 10, 2024Frank TakkinenLake Street$30.00$25.9415.65%12.57%
Jul 02, 2024Frank TakkinenLoop Capital Markets$30.00$26.0215.32%12.57%
May 07, 2024Mike MatsonNeedham$30.00$21.0742.38%12.57%
Row per page
Go to

The latest Artivion stock forecast, released on Oct 23, 2024 by Daniel Stauder from JMP Securities, set a price target of $33.00, which represents a 24.39% increase from the stock price at the time of the forecast ($26.53), and a 23.83% increase from AORT last price ($26.65).

Artivion Price Target by Period


1M3M12M
# Anlaysts115
Avg Price Target$33.00$33.00$30.60
Last Closing Price$26.65$26.65$26.65
Upside/Downside23.83%23.83%14.82%

In the current month, the average price target of Artivion stock is $33.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 23.83% increase as opposed to Artivion's last price of $26.65. This month's average price target is down 0.00% compared to last quarter, and up 7.84% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2024Stifel NicolausMarket OutperformMarket OutperformHold
Oct 23, 2024OppenheimerUnderperformUnderperformHold
Oct 23, 2024JMP SecuritiesMarket OutperformOutperformInitialise
Oct 23, 2024JMP Securities-Market OutperformInitialise
Sep 27, 2024NeedhamBuyBuyHold
Sep 13, 2024Stifel NicolausBuyBuyHold
Aug 09, 2024OppenheimerOutperformOutperformHold
Jul 02, 2024NeedhamBuyBuyHold
Jul 02, 2024Lake StreetBuyBuyHold
May 07, 2024NeedhamBuyBuyHold
Row per page
Go to

Artivion's last stock rating was published by Stifel Nicolaus on Oct 23, 2024. The company gave AORT a "Market Outperform" rating, the same as its previous rate.

Artivion Financial Forecast


Artivion Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$93.67M$87.85M$89.25M$83.23M$79.40M$76.84M$80.34M$77.21M$79.39M$72.21M$76.15M$71.09M$67.90M$65.13M$53.77M$66.43M$69.70M$67.88M
Avg Forecast$123.85M$116.51M$119.61M$117.24M$112.07M$105.71M$107.83M$104.65M$101.15M$94.76M$97.60M$92.06M$89.28M$84.32M$84.24M$80.35M$79.85M$76.19M$77.28M$74.85M$77.77M$72.40M$70.97M$62.97M$66.53M$59.23M$50.46M$66.00M$70.82M$68.29M
High Forecast$125.69M$118.24M$121.39M$118.98M$113.73M$107.28M$109.44M$105.35M$102.24M$94.78M$97.60M$92.06M$89.33M$86.80M$85.49M$81.54M$81.04M$76.19M$77.28M$74.85M$77.77M$72.40M$70.97M$62.97M$66.53M$59.23M$50.46M$66.00M$70.82M$68.29M
Low Forecast$120.68M$113.53M$116.55M$114.24M$109.20M$103.01M$105.07M$103.95M$100.06M$94.74M$97.60M$92.06M$89.23M$83.00M$82.08M$78.29M$77.81M$76.19M$77.28M$74.85M$77.77M$72.40M$70.97M$62.97M$66.53M$59.23M$50.46M$66.00M$70.82M$68.29M
# Analysts111111134211254433334444444433
Surprise %------------1.05%1.04%1.06%1.04%0.99%1.01%1.04%1.03%1.02%1.00%1.07%1.13%1.02%1.10%1.07%1.01%0.98%0.99%

Artivion's average Quarter revenue forecast for Mar 24 based on 1 analysts is $92.06M, with a low forecast of $92.06M, and a high forecast of $92.06M. AORT's average Quarter revenue forecast represents a -1.72% decrease compared to the company's last Quarter revenue of $93.67M (Dec 23).

Artivion EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111134211254433334444444433
EBITDA------------$3.17M$-1.24M$7.67M$2.91M$8.65M$-2.21M$6.42M$7.40M$-6.23M$18.05M$8.66M$5.54M$10.52M$5.93M$3.63M$151.00K$10.23M$7.09M
Avg Forecast$11.87M$11.16M$11.46M$11.23M$10.74M$10.13M$10.33M$10.03M$9.69M$9.08M$9.35M$8.82M$8.55M$8.08M$8.07M$7.70M$7.65M$4.28M$4.34M$14.98M$-14.77M$4.06M$3.98M$3.53M$3.73M$3.32M$2.83M$3.70M$3.97M$3.83M
High Forecast$12.04M$11.33M$11.63M$11.40M$10.90M$10.28M$10.49M$10.09M$9.80M$9.08M$9.35M$8.82M$8.56M$8.32M$8.19M$7.81M$7.76M$4.28M$4.34M$17.98M$-11.82M$4.06M$3.98M$3.53M$3.73M$3.32M$2.83M$3.70M$3.97M$3.83M
Low Forecast$11.56M$10.88M$11.17M$10.95M$10.46M$9.87M$10.07M$9.96M$9.59M$9.08M$9.35M$8.82M$8.55M$7.95M$7.86M$7.50M$7.46M$4.28M$4.34M$11.99M$-17.73M$4.06M$3.98M$3.53M$3.73M$3.32M$2.83M$3.70M$3.97M$3.83M
Surprise %------------0.37%-0.15%0.95%0.38%1.13%-0.52%1.48%0.49%0.42%4.44%2.18%1.57%2.82%1.79%1.28%0.04%2.57%1.85%

1 analysts predict AORT's average Quarter EBITDA for Mar 24 to be $8.82M, with a high of $8.82M and a low of $8.82M. This is 178.07% upper than Artivion's previous annual EBITDA (Dec 23) of $3.17M.

Artivion Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111134211254433334444444433
Net Income------------$-3.98M$-9.80M$-3.38M$-13.53M$2.17M$-13.71M$-4.26M$-3.39M$-20.10M$10.58M$-2.18M$-3.14M$-3.46M$-2.87M$-3.69M$-6.67M$-681.00K$-134.00K
Avg Forecast$7.31M$4.74M$5.30M$4.54M$4.77M$2.03M$1.89M$11.72K$-2.58M$-2.65M$-3.77M$-5.02M$-3.60M$-2.59M$-2.30M$-4.69M$-5.19M$-5.17M$-3.75M$-6.86M$-47.69M$1.04M$42.15M$-3.89M$-1.88M$-3.86M$-7.29M$1.04M$1.18M$694.73K
High Forecast$7.45M$4.83M$5.40M$4.63M$4.86M$2.07M$1.93M$11.94K$-2.49M$-2.56M$-3.64M$-4.85M$-3.48M$432.39K$-2.22M$-4.53M$-5.02M$-5.17M$-3.75M$-5.49M$-38.15M$1.04M$42.15M$-3.89M$-1.88M$-3.86M$-7.29M$1.04M$1.18M$694.73K
Low Forecast$7.06M$4.59M$5.12M$4.39M$4.61M$1.96M$1.83M$11.33K$-2.63M$-2.70M$-3.84M$-5.12M$-3.67M$-4.32M$-2.35M$-4.78M$-5.29M$-5.17M$-3.75M$-8.24M$-57.23M$1.04M$42.15M$-3.89M$-1.88M$-3.86M$-7.29M$1.04M$1.18M$694.73K
Surprise %------------1.10%3.78%1.47%2.89%-0.42%2.65%1.14%0.49%0.42%10.15%-0.05%0.81%1.84%0.74%0.51%-6.40%-0.58%-0.19%

Artivion's average Quarter net income forecast for Mar 23 is $-4.69M, with a range of $-4.78M to $-4.53M. AORT's average Quarter net income forecast represents a -316.07% decrease compared to the company's last Quarter net income of $2.17M (Dec 22).

Artivion SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111134211254433334444444433
SG&A------------$50.28M$51.09M$57.24M$50.37M$38.45M$41.05M$38.98M$38.95M$51.25M$39.05M$40.83M$38.64M$36.10M$33.74M$32.29M$39.00M$37.61M$34.26M
Avg Forecast$67.75M$63.74M$65.44M$64.14M$61.31M$57.83M$58.99M$57.25M$55.34M$51.84M$53.39M$50.36M$48.84M$46.13M$46.08M$43.95M$43.68M$40.02M$40.59M$39.32M$40.85M$38.03M$37.28M$33.08M$34.95M$31.11M$26.51M$34.67M$37.20M$35.87M
High Forecast$68.76M$64.69M$66.41M$65.09M$62.22M$58.69M$59.87M$57.63M$55.93M$51.85M$53.39M$50.36M$48.87M$47.48M$46.77M$44.61M$44.33M$40.02M$40.59M$39.32M$40.85M$38.03M$37.28M$33.08M$34.95M$31.11M$26.51M$34.67M$37.20M$35.87M
Low Forecast$66.02M$62.11M$63.76M$62.49M$59.74M$56.35M$57.48M$56.87M$54.74M$51.83M$53.39M$50.36M$48.81M$45.41M$44.90M$42.83M$42.56M$40.02M$40.59M$39.32M$40.85M$38.03M$37.28M$33.08M$34.95M$31.11M$26.51M$34.67M$37.20M$35.87M
Surprise %------------1.03%1.11%1.24%1.15%0.88%1.03%0.96%0.99%1.25%1.03%1.10%1.17%1.03%1.08%1.22%1.12%1.01%0.96%

Artivion's average Quarter SG&A projection for Mar 24 is $50.36M, based on 1 Wall Street analysts, with a range of $50.36M to $50.36M. The forecast indicates a 0.16% rise compared to AORT last annual SG&A of $50.28M (Dec 23).

Artivion EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111134211254433334444444433
EPS------------$-0.10$-0.24$-0.08$-0.33$0.05$-0.34$-0.11$-0.09$-0.51$0.27$-0.06$-0.08$-0.09$-0.08$-0.10$-0.18$-0.02$-0.00
Avg Forecast$0.17$0.11$0.13$0.11$0.11$0.05$0.05-$-0.06$-0.06$-0.09$-0.12$-0.09$-0.06$-0.06$-0.11$-0.12$-0.12$-0.09$-0.12$-0.06$0.03$1.01$-0.09$-0.04$-0.09$-0.17$0.03$0.03$0.02
High Forecast$0.18$0.12$0.13$0.11$0.12$0.05$0.05-$-0.06$-0.06$-0.09$-0.12$-0.08$0.01$-0.05$-0.11$-0.12$-0.12$-0.09$-0.12$-0.06$0.03$1.01$-0.09$-0.04$-0.09$-0.17$0.03$0.03$0.02
Low Forecast$0.17$0.11$0.12$0.10$0.11$0.05$0.04-$-0.06$-0.06$-0.09$-0.12$-0.09$-0.10$-0.06$-0.11$-0.13$-0.12$-0.09$-0.12$-0.06$0.03$1.01$-0.09$-0.04$-0.09$-0.17$0.03$0.03$0.02
Surprise %------------1.13%3.87%1.51%2.95%-0.40%2.74%1.22%0.69%8.50%10.80%-0.06%0.86%2.00%0.86%0.57%-7.20%-0.71%-0.22%

According to 4 Wall Street analysts, Artivion's projected average Quarter EPS for Mar 23 is $-0.11, with a low estimate of $-0.11 and a high estimate of $-0.11. This represents a -324.00% decrease compared to AORT previous annual EPS of $0.05 (Dec 22).

Artivion Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SGHTSight Sciences$3.80$9.00136.84%Hold
ESTAEstablishment Labs$37.79$78.00106.40%Buy
LUNGPulmonx$6.34$11.9388.17%Buy
KIDSOrthoPediatrics$22.93$39.6072.70%Buy
SIBNSI-BONE$12.92$20.0054.80%Buy
NPCENeuroPace$8.98$12.8843.43%Buy
CNMDCONMED$72.24$96.0032.89%Buy
OFIXOrthofix Medical$18.08$24.0032.74%-
AVNSAvanos Medical$18.68$23.0023.13%Hold
CVRXCVRx$13.91$16.3317.40%Buy
AORTArtivion$26.65$30.6014.82%Buy
ITGRInteger$133.18$138.003.62%Buy
SRDXSurmodics$38.72$39.502.01%Buy

AORT Forecast FAQ


Is Artivion a good buy?

Yes, according to 4 Wall Street analysts, Artivion (AORT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of AORT's total ratings.

What is AORT's price target?

Artivion (AORT) average price target is $30.6 with a range of $30 to $33, implying a 14.82% from its last price of $26.65. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Artivion stock go up soon?

According to Wall Street analysts' prediction for AORT stock, the company can go up by 14.82% (from the last price of $26.65 to the average price target of $30.6), up by 23.83% based on the highest stock price target, and up by 12.57% based on the lowest stock price target.

Can Artivion stock reach $40?

AORT's average twelve months analyst stock price target of $30.6 does not support the claim that Artivion can reach $40 in the near future.

What is Artivion's current price target trend?

1 Wall Street analyst forecast a $33 price target for Artivion (AORT) this month, up 23.83% from its last price of $26.65. Compared to the last 3 and 12 months, the average price target increased by 23.83% and increased by 14.82%, respectively.

What are Artivion's analysts' financial forecasts?

Artivion's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $430.26M (high $435.8M, low $421.23M), average EBITDA is $41.23M (high $41.76M, low $40.36M), average net income is $8.71M (high $8.87M, low $8.42M), average SG&A $235.38M (high $238.41M, low $230.44M), and average EPS is $0.208 (high $0.212, low $0.201). AORT's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $477.22M (high $484.31M, low $465M), average EBITDA is $45.72M (high $46.4M, low $44.55M), average net income is $21.89M (high $22.31M, low $21.16M), average SG&A $261.06M (high $264.94M, low $254.38M), and average EPS is $0.523 (high $0.533, low $0.506).

Did the AORT's actual financial results beat the analysts' financial forecasts?

Based on Artivion's last annual report (Dec 2023), the company's revenue was $354M, beating the average analysts forecast of $338.19M by 4.68%. Apple's EBITDA was $5.74M, missing the average prediction of $32.4M by -82.28%. The company's net income was $-30.69M, beating the average estimation of $-13.181M by 132.84%. Apple's SG&A was $208.98M, beating the average forecast of $185.01M by 12.96%. Lastly, the company's EPS was $-0.75, beating the average prediction of $-0.315 by 138.10%. In terms of the last quarterly report (Dec 2023), Artivion's revenue was $93.67M, beating the average analysts' forecast of $89.28M by 4.92%. The company's EBITDA was $3.17M, missing the average prediction of $8.55M by -62.92%. Artivion's net income was $-3.975M, beating the average estimation of $-3.599M by 10.46%. The company's SG&A was $50.28M, beating the average forecast of $48.84M by 2.94%. Lastly, the company's EPS was $-0.0972, beating the average prediction of $-0.086 by 13.02%